NOVEL SMALL MOLECULE HPK1 INHIBITOR PCC-1 INDUCES STRONG ANTI-TUMOR ACTIVITY

被引:0
|
作者
Das, Sanjib [1 ]
Mandadi, Sravan [1 ]
Saini, Jagmohan [1 ]
Chaudhari, Sachin [1 ]
Deshpande, Ameya [1 ]
Chinnapattu, Murugan [1 ]
Bajpai, Malini [1 ]
Pangre, Priyanka [1 ]
Potdar, Varada [1 ]
Marathe, Megha [1 ]
Sawant, Pooja [1 ]
Akarte, Atul [1 ]
Misra, Chandrasekhar [2 ]
Das, Subhadip [1 ]
Singh, Anuj [1 ]
Das, Avratanu [1 ]
Lambade, Pandurang [1 ]
Tirumalasetty, Chaitanya [1 ]
Patole, Raju [1 ]
Biswas, Nilanjana [1 ]
Karande, Vikas [1 ]
Shah, Heta [1 ]
Behera, Dayanidhi [1 ]
Gowda, Nagaraj [1 ]
Iyer, Pravin [1 ]
机构
[1] Glenmark Pharmaceut Ltd, Navi Mumbai, India
[2] Glenmark Pharmaceut, Navi Mumbai, India
关键词
D O I
10.1136/jitc-2021-SITC2021.848
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
848
引用
收藏
页码:A889 / A889
页数:1
相关论文
共 50 条
  • [1] Novel small molecule HPK1 inhibitor induces immunogenic anti-tumor effects.
    Chaudhari, Sachin S.
    Bajpai, Malini
    Mandadi, Sravan
    Kattige, Vidya G.
    Thorat, Sandeep
    Potdar, Varada
    Pangre, Priyanka
    Sawant, Pooja
    Misra, Chandrasekhar
    Das, Subhadip
    Akarte, Atul
    Singh, Anuj
    Mahankali, Sandeep
    Lambade, Pandurang
    Das, Avratanu
    Patole, Raju
    Udupa, Venkatesha
    Sancheti, Pavankumar
    Pawar, Pramod K.
    Kakade, Somesh
    Vinod, K. R.
    Biswas, Nilanjana
    Shah, Heta
    Behera, Dayanidhi
    Jain, Pankaj
    Gowda, Nagaraj
    Iyer, Pravin S.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
    You, Dan
    Hillerman, Stephen
    Locke, Gregory
    Chaudhry, Charu
    Stromko, Caitlyn
    Murtaza, Anwar
    Fan, Yi
    Koenitzer, Jennifer
    Chen, Yali
    Briceno, Stephanie
    Bhadra, Rajarshi
    Duperret, Elizabeth
    Gullo-Brown, Johnni
    Gao, Chan
    Zhao, Dandan
    Feder, John
    Curtin, Joshua
    Degnan, Andrew P.
    Kumi, Godwin
    Wittman, Mark
    Johnson, Benjamin M.
    Parrish, Karen E.
    Gokulrangan, Giridharan
    Morrison, John
    Quigley, Michael
    Hunt, John T.
    Salter-Cid, Luisa
    Lees, Emma
    Sanjuan, Miguel A.
    Liu, Jinqi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)
  • [3] Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
    Setsu, Genzui
    Goto, Megumi
    Ito, Kentaro
    Taira, Tomoe
    Miyamoto, Masaya
    Watanabe, Tomohiro
    Taniguchi, Toru
    Umezaki, Yuma
    Nakazawa, Yusuke
    Uesugi, Shuhei
    Mori, Kazuki
    Horiuchi, Takao
    Obuchi, Wataru
    Minami, Masako
    Shimada, Takashi
    Wada, Chisa
    Yoshida, Takanori
    Higuchi, Saito
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [4] The role of HPK1 in the regulation of T cell function and anti-tumor immune activity
    Chen, Yaoyu
    Rios-Doria, Jonathan
    Pusey, Michelle
    Lasky, Kerri
    Ye, Min
    Thekkat, Pramod
    Gallagher, Karen
    Stump, Kristine
    Conlen, Patricia
    Gardiner, Christine
    Wang, Hui
    Sokolsky, Alexander
    Rupar, Mark
    Lin, Luping
    Behshad, Elham
    Covington, Maryanne
    Koblish, Holly
    Vechorkin, Oleg
    Yao, Wenqing
    Kim, Sunkyu
    Chen, Yingnan
    CANCER RESEARCH, 2020, 80 (16)
  • [5] Discovery of JNJ-787: An Hpk1 inhibitor that enhances the anti-tumor immunity of anti-PD1 in mice
    Mevellec, Laurence
    Descamps, Sophie
    Adelinet, Christophe
    Wroblowski, Berthold
    Vreys, Veronique
    Valckx, Annemie
    Boeckx, Inge
    Van Slycken, Nele
    Paulussen, Caroline
    Leclercq, Laurent
    Verhulst, Tinne
    Van der Leede, Bas-jan
    Angibaud, Patrick
    Meerpoel, Lieven
    Edwards, James
    Laquerre, Sylvie
    Lorenzi, Matt
    Vialard, Jorge
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [6] Development and characterization of small molecule HPK1 inhibitors
    Chmielewski, Stefan
    Kujawa, Maciej
    Zimolag, Eliza
    Guzik, Pawel
    Dudek, Agata
    Topolnicki, Grzegorz
    Sudol, Sylwia
    Gibas, Agnieszka
    Bugaj, Marta
    Krolenko, Kostiantyn
    Nowogrodzki, Marcin
    Janiga, Anita
    Wyrebek, Przemyslaw
    Pieta, Jakub
    Brzdonkiewicz, Aleksandra
    Wilkowski, Grzegorz
    Walczak, Marcin
    Maciejewska, Katarzyna
    Radzimierski, Adam
    Jasnosz, Wojciech
    Mahajan, Tushar
    Bartolotta, Roberta
    Gluza, Karolina
    Kret, Patryk
    Rutkowska, Ewelina
    Michalik, Kinga
    Banaszak, Katarzyna
    Podkowa, Adrian
    Golas, Aniela
    Wnuk-Lipinska, Katarzyna
    Fabritius, Charles
    Stasi, Luigi
    Littlewood, Peter
    Brzozka, Krzysztof
    Bartosik, Anna
    Dobrzanska, Monika
    CANCER RESEARCH, 2020, 80 (16)
  • [7] ISM9182A, a novel HPK1 inhibitor, exhibits immune modulatory activity and robust monotherapy anti-tumor effects in preclinical studies
    Chen, Celia X-J
    Pu, Congying
    Peng, Jingjing
    Ding, Xiaoyu
    Lu, Hongfu
    Ding, Xiao
    Zhang, Man
    Bavadekar, Supriya
    Rao, Sujata
    Ren, Feng
    Zhavoronkov, Alex
    CANCER RESEARCH, 2024, 84 (06)
  • [8] NOVEL, ORALLY ADMINISTERED HPK1 INHIBITORS DEMONSTRATE ANTI-TUMOR EFFICACY AND ENHANCED IMMUNE RESPONSE
    Chmielewski, Stefan
    Kujawa, Maciej
    Zimolag, Eliza
    Galezowski, Michal
    Gondela, Andrzej
    Guzik, Pawel
    Dudek, Agata
    Szeremeta-Spisak, Joanna
    Bugaj, Marta
    Levenets, Iana
    Nowogrodzki, Marcin
    Girardi, Marianna
    Zagorska, Anna
    Wyrebek, Przemyslaw
    Zastawna, Magdalena
    Gibas, Agnieszka
    Sudol, Sylwia
    Levenets, Oleksandr
    Swirski, Mateusz
    Sasmal, Sujit
    Radzimierski, Adam
    Sowinska, Marta
    Niedziejko, Paulina
    Zuchowicz, Karol
    Swarbrick, Martin
    Gluza, Karolina
    Kret, Patryk
    Ogorek, Mateusz
    Stanko, Dominika
    Michalik, Kinga
    Piatek, Agnieszka
    Banaszak, Katarzyna
    Podkowa, Adrian
    Golas, Aniela
    Littlewood, Peter
    Brzozka, Krzysztof
    Chielewski, Stefan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A786 - A786
  • [9] Development and characterization of small molecule HPK1 inhibitors.
    Kujawa, Maciej
    Zimolag, Eliza
    Galezowski, Michal
    Guzik, Pawel
    Dudek, Agata
    Gondela, Andrzej
    Nowogrodzki, Marcin
    Girardi, Marianna
    Krolenko, Kostiantyn
    Bugaj, Marta
    Sudol, Sylwia
    Gibas, Agnieszka
    Szeremeta-Spisak, Joanna
    Bobowska, Aneta
    Zastawna, Magdalena
    Wyrebek, Przemyslaw
    Boutard, Nicolas
    Wieckowska, Aleksandra
    Jasnosz, Wojciech
    Schonemann, Wojciech
    Zuchowicz, Karol
    Synak, David
    Kulesza, Urszula
    Leventes, Oleksandr
    Swirski, Mateusz
    Sasmal, Sujit
    Gluza, Karolina
    Kret, Patryk
    Ogorek, Mateusz
    Michalik, Kinga
    Banaszak, Katarzyna
    Podkowa, Adrian
    Wnuk-Lipinska, Katarzyna
    Dobrzanska, Monika
    Littlewood, Peter
    Brzozka, Krzysztof
    Bartosik, Anna
    Chmielewski, Stefan
    CANCER RESEARCH, 2021, 81 (13)
  • [10] A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model
    Liu, Hao
    Wu, Lei
    Feng, Song
    Huang, Wei
    Li, Huijuan
    Lin, Jing
    Liu, Yangyang
    Mei, Liufeng
    Ren, Baoqi
    Xie, Julie
    Yao, Lili
    Zhong, Wenge
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)